Aluminum toxicity is a problem in dialysis patients and has been suggested
as mechanism in disturbed lymphocyte function in renal insufficiency. Howev
er, intracellular aluminum concentrations in B- and T-lymphocytes have not
been determined in detail. Therefore, we studied total intracellular lympho
cytic aluminum content in B- and T-cells in 10 patients on regular hemodial
ysis (duration 3,1 +/- 1,1 years) and 11 healthy control subjects. Addition
ally, B- and T-lymphocytic aluminum concentrations were determined after is
olating of T-cells using resetting procedures with neuramidase-treated shee
p red blood cells. Aluminum concentrations were measured by atomic absorpti
on spectroscopy. Since lymphocytic volume cannot easily be determined, we r
eferred aluminum content to the amount of lymphocytic protein content measu
red by the Bradford method. Total aluminum content was significantly increa
sed in dialysis patients compared to control subjects (5.2 +/- 1.7 I-IS Al/
g (MW +/- SD) vs. 3.6 1 1.2 mu g Al/g lymphocytic protein, p < 0.05). T-cel
l aluminum content was not significantly different between groups (2.2 +/-
1.4 versus 2.2 +/- 0.9 mu g Al/g). In contrast, aluminum concentrations in
B-cells were significantly increased in dialysis patients (2.9 +/- 0.7 vers
us 1.44 +/- 0.5 mu g Al/g lymphocytic proteins, p < 0.05)Our results indica
te that beside the well-known altertions in plasma aluminum concentrations
intracellular B-cell aluminum content is increased in patients on regular d
ialysis patients, This might contribute to impaired immune response in pati
ents with renal insufficiency.